New Stomach-Slimming procedure tested for ulcerative colitis patients

NCT ID NCT05739162

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 4 times

Summary

This study is testing a minimally invasive weight loss procedure called endoscopic sleeve gastroplasty (ESG) in 12 people who have both obesity and ulcerative colitis and are planning or have had colon removal surgery. The procedure uses a suturing device to reduce stomach size by 70-80%, and participants also follow a personalized low-calorie diet and exercise plan. The goal is to see if ESG is safe and effective for weight loss in this specific group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Endoscopic sleeve gastroplasty (ESG) using the Apollo Endoscopic Suture System, plus a personalized low-calorie diet and physical activity plan
What this could lead to
If it works, this could offer a safe weight-loss option for obese UC patients before or after colon removal surgery, potentially reducing surgical complications.
What could go wrong
This is a very small early study (12 people) with no control group, so results may not apply broadly. The procedure carries risks like bleeding or infection, and weight loss may not be sustained.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic Minnesota

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.